AxoGen, Inc. (NASDAQ:AXGN) Q3 2023 Earnings Call Transcript

Page 3 of 3

Dave Turkaly: Thank you.

Karen Zaderej: Thanks, Dave.

Pete Mariani: Thanks, Dave.

Operator: Thank you. At this time, we’ve reached the end of our question-and-answer session, and I’ll turn the call over to Karen Zaderej for closing remarks.

Karen Zaderej: Thank you, Rob. I’d like to thank the AxoGen team who remain committed to our mission of improving nerve function and quality of life for patients with peripheral nerve injuries. We’re happy with our current progress, and we remain focused on ensuring our long-term success. I want to thank everyone for joining us this morning, and have a great day.

Operator: This will conclude today’s conference. You may disconnect your lines at this time. Thank you for your participation.

Follow Axogen Inc. (NASDAQ:AXGN)

Page 3 of 3